SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
CSC's DynPort Vaccine Company LLC Wins $32.3 Million National Institute of Allergy And Infectious Diseases (NIAID) Contract to Establish Phase 1 Clinical Trial